137 related articles for article (PubMed ID: 1898511)
1. Estrogen replacement therapy and osteoporosis.
Gambrell RD
Hosp Pract (Off Ed); 1991; 26 Suppl 1():30-5. PubMed ID: 1898511
[TBL] [Abstract][Full Text] [Related]
2. [Drug therapy of osteoporosis].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2263-4. PubMed ID: 14508549
[No Abstract] [Full Text] [Related]
3. [The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
Novak S
Reumatizam; 2008; 55(2):75-7. PubMed ID: 19024282
[TBL] [Abstract][Full Text] [Related]
4. [Compression vertebral fracture in osteoporosis--prevention and treatment].
Vlak T
Reumatizam; 2004; 51(2):50-3. PubMed ID: 15554379
[TBL] [Abstract][Full Text] [Related]
5. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
6. Fracture prevention in postmenopausal women.
Bruyere O; Reginster JY; Edwards J
Clin Evid; 2002 Dec; (8):1089-102. PubMed ID: 12603931
[No Abstract] [Full Text] [Related]
7. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
Leidig-Bruckner G; Ziegler R
Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
[TBL] [Abstract][Full Text] [Related]
8. [Delaying degeneration or promoting regeneration. 2 successful strategies in osteoporosis].
MMW Fortschr Med; 2004 Mar; 146(10):46. PubMed ID: 15347088
[No Abstract] [Full Text] [Related]
9. Fluoride and bone: a second look. No use in osteoporosis.
Prescrire Int; 1998 Aug; 7(36):110-1. PubMed ID: 10342949
[TBL] [Abstract][Full Text] [Related]
10. Fracture prevention in postmenopausal women.
Bruyere O; Reginster JY
Clin Evid; 2002 Jun; (7):979-82. PubMed ID: 12230720
[No Abstract] [Full Text] [Related]
11. [Effects of SERMs on bone health. Efficacy of SERM for incidence of fractures in osteoporotic patients with lifestyle-related diseases].
Sakai A; Nakamura T
Clin Calcium; 2010 Mar; 20(3):322-9. PubMed ID: 20190361
[TBL] [Abstract][Full Text] [Related]
12. Another selective estrogen-receptor modulator for osteoporosis.
Becker C
N Engl J Med; 2010 Feb; 362(8):752-4. PubMed ID: 20181977
[No Abstract] [Full Text] [Related]
13. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
[TBL] [Abstract][Full Text] [Related]
14. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
[TBL] [Abstract][Full Text] [Related]
15. Lasofoxifene in postmenopausal women with osteoporosis.
Cummings SR; Ensrud K; Delmas PD; LaCroix AZ; Vukicevic S; Reid DM; Goldstein S; Sriram U; Lee A; Thompson J; Armstrong RA; Thompson DD; Powles T; Zanchetta J; Kendler D; Neven P; Eastell R;
N Engl J Med; 2010 Feb; 362(8):686-96. PubMed ID: 20181970
[TBL] [Abstract][Full Text] [Related]
16. [Osteoporosis. Fracture as alarm signal].
MMW Fortschr Med; 2001 Oct; 143(41):56. PubMed ID: 11721665
[No Abstract] [Full Text] [Related]
17. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
[TBL] [Abstract][Full Text] [Related]
18. [Estrogen, risk of fracture and osteoporosis].
Waller G
Lakartidningen; 2002 Jan; 99(3):209. PubMed ID: 11838083
[No Abstract] [Full Text] [Related]
19. [Should bisphosphonate treatment be used for super-old patients with osteoporosis?].
Harada A; Yamamoto S; Kurato S; Iwase T; Inoue K; Sasaki Y; Tanaka T; Fujita M; Nakano T; Ando F
Nihon Ronen Igakkai Zasshi; 2006 Jul; 43(4):459-61. PubMed ID: 16937933
[No Abstract] [Full Text] [Related]
20. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
Iwamoto J
Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
